🇺🇸 FDA
Patent

US 11608503

RNA targeting of mutations via suppressor tRNAs and deaminases

granted A61KA61K38/00A61P

Quick answer

US patent 11608503 (RNA targeting of mutations via suppressor tRNAs and deaminases) held by The Regents of the University of California expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/00, A61P, A61P21/00